Skip to main content
. Author manuscript; available in PMC: 2026 Aug 4.
Published in final edited form as: Handb Clin Neurol. 2018;148:441–464. doi: 10.1016/B978-0-444-64076-5.00029-6

Table 29.3.

PRNP nonsense mutations

PRNP mutation Codon 129 polymorphism # of cases in literature Clinical phenotypes Age at onset (range)c (years) Disease duration (range)c (months or years) Positive FHxa CSF marker sensitivity
EEG PSWC MRI c/w JCDb Neuropathology Neuropathology pheno-type References
14-3-3 Total tau
Q145X MM 1 Cog 38 21 years 0% (0/1) N/A N/A N/A N/A NFT, PrP-angio Atypic Ghetti et al. (1996)
Q160X MM (4) MV (3) Unknown (4) 11 D Cog, Dep Cog, dysauto, neuropathy 42.1±8.4 (32–59) 9.6±4.9 (4–21) years 100% (11/11) 0% (0/1) 0% (0/1) 0% (0/4) 0% (0/4) NFT, PrP-angio, AD pathology Atypical Owen et al. (1989); Finckh et al.(2000) ; Jayadev et al. (2011); Fong et al., 2016
Q163X Cis V (10) 10 Dysauto, neuropathy, Cog 33.0 ±3.4 (30–38) 26.8 ±8.0 (15–33) years 100% (10/10) 100% (1/1) 100%d (1/1) 0% (0/3) 0% (0/2) NFT, PrP-angio, PrP-Plaqs, Sp, V Atypical Mead et al. (2013)
Y226X MV (2) Unknown (1) 3 D Park, Cog 55.3 ±17.0 (39–73) 3.5 ±2.3 (1.5–6) years 100% (3/3) 100% (1/1) N/A 100% (1/1) 0% (0/1) PrP-angio, PrP-Plaqs Atypical Jansen et al. (2010)
2bp Del 178 Unknown (3) 3 Dysauto, cog, neuropathy 42.0± 14.0 (26–52) 5.5± 6.4 (1–10) years 100% (3/3) 100% (2/2) 100% (1/1) N/A 0% (0/2) N/A Atypical Matsuzono et al. (2013)

From Kim et al. (2017) with permission from Cold Spring Harbor Laboratory Press.

a

Positive family history of dementia with similar clinical features (as of the proband) or prion disease.

b

According to most commonly used European 2009 and UCSF 2011 criteria (Zerr et al., 2009; Vitali et al., 2011).

c

Data on age at onset and duration of disease are shown as mean ± sd (range), unless otherwise indicated.

d

Positive if > total tau 1200 pg/mL.

AD, Alzheimer-type dementia; Cog, cognitive; c/w, consistent with; D, dementia; Dep, depression; Dysauto, dysautonomia; EEG, electroencephalogram; FHx, family history; JCD, Jakob–Creutzfeldt disease; MRI, magnetic resonance imaging; N/A, not available; NFT, neurofibrillary tangles; Park, parkinsonism; PrP-angio, PrP amyloid angiopathy; PrP-Plqs, PrP-amyloid plaques; PSWC, periodic sharp-wave complexes; Sp, spongiosis; V, vacuolation.